PanCAD.ai

Editorial Policy

1. Content Sources

Content on this site is produced by the PanCAD.ai team; technical and clinical information derives from research by Prof. Wei-Chung Wang's team (National Taiwan University) and Prof. Wei-Chih Liao's team (NTU Hospital).

2. Evidence First

Claims are supported by published literature or applicable regulatory documentation. The six peer-reviewed papers listed here can be verified on PubMed, and regulatory status can be checked in official databases.

3. Data Honesty

We present performance with research data (for example, the cited 92.1% sensitivity result for tumors under 2 cm and AUC 0.95) and identify the study population and limitations.

4. Review & Updates

Content is reviewed and updated regularly; major clinical or regulatory changes are reflected promptly with version dates in the footer.

5. Corrections

If you find an error, contact [email protected] and we will verify and correct it promptly.